<DOC>
<DOCNO>
EP-0011651
</DOCNO>
<TEXT>
<DATE>
19800611
</DATE>
<IPC-CLASSIFICATIONS>
C07D-307/00 A61P-7/00 A61P-9/00 C07D-333/78 C07D-495/00 C07D-495/10 A61K-31/38 A61P-7/02 C07D-307/33 C07D-333/00 C07D-333/50 A61K-31/381 <main>C07D-333/64</main> 
</IPC-CLASSIFICATIONS>
<TITLE>
pharmaceutical composition comprising 3-oxo-2,3-dihydro-(1)-benzothiophene-2-spirocyclopropane and this compound for use in the prophylaxis or treatment of cardiovascular disturbance.
</TITLE>
<APPLICANT>
takeda chemical industries ltdjp  <sep>takeda chemical industries, ltd.<sep>takeda chemical industries, ltd.1-1, doshomachi 4-chomechuo-ku, osakajp<sep>takeda chemical industries, ltd. <sep>
</APPLICANT>
<INVENTOR>
fujimura hajime<sep>hori mikio<sep>fujimura, hajime<sep>hori, mikio<sep>fujimura, hajime9-2, shishigatani-shimomiya nomaechosakyo-ku,kyoto-shi kyoto 606jp<sep>hori, mikio33-1, honmachi 5-chomegifu-shi, gifu 500jp<sep>fujimura, hajime <sep>hori, mikio<sep>fujimura, hajime9-2, shishigatani-shimomiya nomaechosakyo-ku,kyoto-shi kyoto 606jp<sep>hori, mikio33-1, honmachi 5-chomegifu-shi, gifu 500jp<sep>
</INVENTOR>
<ABSTRACT>
a known compound, 3-oxo-2, 3-dihydro (1)  benzothiophene-2-spirocyclopropane as represented by the  following formula may inhibit agglutination of platelets in  mammalian blood.  this invention intends to use said com­ pound and medical compositions including the same com­ pound for the prevention or remedy of circulatory failure  desease such as thrombosis.  
</ABSTRACT>
</TEXT>
</DOC>
